Endo-histologic outcomes in patients with ulcerative colitis responding to tofacitinib

被引：0
|
作者：
Singh, D. M. A. [1 ]
Bhardwaj, A. [1 ]
Jain, D. [1 ]
Sharma, R. [1 ]
Singh, D. [1 ]
Mahajan, R. [1 ]
Kaur, K. [2 ]
Singh, A. [3 ]
Narang, V [3 ]
Kaur, H. [3 ]
Singh, M. [4 ]
Gupta, P. [4 ]
Sehgal, T. [4 ]
Midha, V [4 ]
Sood, A. [1 ]
机构：
[1] Dayanand Med Coll & Hosp, Gastroenterol, Ludhiana, India
[2] Dayanand Med Coll & Hosp, Pharmacol, Ludhiana, India
[3] Dayanand Med Coll & Hosp, Pathol, Ludhiana, India
[4] Dayanand Med Coll & Hosp, Med, Ludhiana, India
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1278
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1104
引用
收藏
页码：i2033 / i2034
页数：2
相关论文
共 50 条
  • [41] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - UPDATED RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
    Sands, Bruce E.
    Taub, Pam R.
    Feagan, Brian G.
    Armuzzi, Alessandro
    Damiao, Aderson O.
    Lawendy, Nervin
    Solano, Gaston
    Kwok, Kenneth
    Woolcott, John
    Salese, Leonardo
    Su, Chinyu
    GASTROENTEROLOGY, 2020, 158 (06) : S1190 - S1190
  • [42] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE TOFACITINIB OCTAVE ULCERATIVE COLITIS CLINICAL PROGRAM
    Vermeire, Severine
    Armuzzi, Alessandro
    Kwok, Kenneth K.
    Lawendy, Nerrvin
    Woolcott, John
    Salese, Leonardo
    Su, Chinyu
    Hudesman, David
    GASTROENTEROLOGY, 2021, 160 (06) : S353 - S353
  • [43] Real World Outcomes of Tofacitinib for Ulcerative Colitis at 52 and 78 Weeks
    Dalal, Rahul
    Sharma, Puza
    Bains, Kanwal
    Pruce, Jordan
    Allegretti, Jessica R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S660 - S661
  • [44] Tofacitinib for the Treatment of Ulcerative Colitis: An Updated Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program
    Winthrop, Kevin L.
    Loftus, Edward V., Jr.
    Baumgart, Daniel C.
    Hart, Ailsa
    Alharbi, Othman R.
    Salese, Leonardo
    Lawendy, Nervin
    Mundayat, Rajiv
    Su, Chinyu
    Reinisch, Walter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S323
  • [45] Efficacy of High Dose Tofacitinib in Refractory Ulcerative Colitis Patients
    Ansari, Usman S.
    Abraham, Bincy P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S323 - S324
  • [46] Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib
    Winthrop, K. L.
    Melmed, G. Y.
    Vermeire, S.
    Long, M. D.
    Chan, G.
    Pedersen, R. D.
    Lawendy, N.
    Thorpe, A. J.
    Nduaka, C. I.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S364 - S364
  • [47] Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
    Winthrop, Kevin L.
    Melmed, Gil Y.
    Vermeire, Severine
    Long, Millie D.
    Chan, Gary
    Pedersen, Ronald D.
    Lawendy, Nervin
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S327 - S328
  • [48] Review article: guide to tofacitinib dosing in patients with ulcerative colitis
    Irving, Peter M.
    Leung, Yvette
    Dubinsky, Marla C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (07) : 1131 - 1145
  • [49] IMPACT OF DISEASE DURATION ON TOFACITINIB EFFICACY IN PATIENTS WITH ULCERATIVE COLITIS
    Travis, Simon P.
    Dotan, Iris
    Danese, Silvio
    Chiorean, Michael V.
    Yamamoto-Furusho, Jesus K.
    de Leon, Dario Ponce
    Su, Chinyu
    Paulissen, Jerome
    Maller, Eric S.
    Modesto, Irene
    Colombel, Jean Frederic
    GASTROENTEROLOGY, 2020, 158 (06) : S1199 - S1199
  • [50] Tofacitinib in ulcerative Colitis - rapid Response in 1/3 of Patients
    Stallmach, A.
    GASTROENTEROLOGE, 2020, 15 (01): : 2 - 2
12345